KRT17 and cervical carcinoma: Previous studies have demonstrated that KRT17 could promote the progression of various malignancies, such as breast cancer,34 cervical carcinoma,35, 36, 37 gastric cancer,38 non–small‐cell lung cancer39 and skin squamous carcinoma.40